"10.1371_journal.pone.0147391","plos one","2016-01-25T00:00:00Z","Sam Tsz Wai Cheng; Lihua Chen; Stephen Yu Ting Li; Eric Mayoux; Po Sing Leung","School of Biomedical Sciences, The Chinese University of Hong Kong, Sha Tin, Hong Kong; Boehringer-Ingelheim Pharma GmbH & Co KG, Biberach, Germany","Conceived and designed the experiments: STWC PSL. Performed the experiments: STWC LC SYTL. Analyzed the data: STWC PSL. Contributed reagents/materials/analysis tools: PSL EM. Wrote the paper: STWC PSL.","The authors received a research grant from Boehringer-Ingelheim, the employer of Eric Mayoux. Boehringer-Ingelheim are makers of the drug Empagliflozin and provided this drug for the experiments in this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","01","Sam Tsz Wai Cheng","STWC",5,TRUE,2,3,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
